MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1 p
30. juuni, 22:00:00 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
Uudised
Veebiallikatest ja uudistepartneritelt
Simply Wall Street
·
41 minuti eest
EBay (EBAY) Tightens Seller Rules In Australia And The US
MarketBeat
·
31 minuti eest
Quantum-Si (NASDAQ:QSI) Stock Rating Raised to "Hold" at Wall Street Zen
MarketBeat
·
31 minuti eest
Rush Enterprises (NASDAQ:RUSHA) Rating Lowered to Hold at Wall Street Zen
Yahoo Finance
·
7 tunni eest
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Profiil
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia